SINGAPORE--March 31, 2023--Horizon Quantum Computing, a Singapore-based company building software development tools to unlock the potential of quantum computing hardware, announced today that it has raised USD 18.1 million Series A...
Marina Biotech is a clinical stage biotechnology company focused on development and commercialization of therapeutic products for rare diseases based on RNA interference (RNAi). The company is developing proprietary single and double-stranded nucleic acid therapeutics including siRNAs, microRNA mimics, antagomirs, and antisense compounds intended to trigger various RNA-based mechanisms of action including RNA interference, microRNA replacement therapy, microRNA inhibition and mRNA translational inhibition, respectively.
© 2023 Pappas Capital, LLC. ALL RIGHTS RESERVED.